Skip to main navigation menu Skip to main content Skip to site footer

Large-scale genotyping of lung cancer.

Genotipificación a gran escala en cáncer de pulmón.



Open | Download

How to Cite

1.
Reguart N, Cardona AF, Cuello M, Arrieta Óscar. Large-scale genotyping of lung cancer. Rev. colomb. hematol. oncol. [Internet]. 2012 Jul. 1 [cited 2025 Dec. 5];1(2):9-11. https://doi.org/10.51643/22562915.293

Download Citation

Citations


Section
Editorial

How to Cite
1.
Reguart N, Cardona AF, Cuello M, Arrieta Óscar. Large-scale genotyping of lung cancer. Rev. colomb. hematol. oncol. [Internet]. 2012 Jul. 1 [cited 2025 Dec. 5];1(2):9-11. https://doi.org/10.51643/22562915.293

Dimensions
PlumX
Noemí Reguart
    Andrés Felipe Cardona
      Mauricio Cuello
        Óscar Arrieta

          Noemí Reguart,

          1
          Departamento de Oncología Médica, Sección Oncología Torácica, Hospital Clínico y Provincial de Barcelona (Barcelona, España).


          Andrés Felipe Cardona,

          Grupo Oncología Clínica y Traslacional, Instituto de Oncología, Fundación Santa Fe de Bogotá (Bogotá, Colombia).


          Mauricio Cuello,

          Departamento Básico de Medicina, Hospital de Clínicas Universidad de la República (UdelaR) (Montevideo, Uruguay).


          Óscar Arrieta,

          Clínica de Oncología Torácica y Laboratorio de Oncología Experimental, Instituto Nacional de Cancerología de México (INCAN) (México D.F., México)



          Article visits 175 | PDF visits 292


          Downloads

          Download data is not yet available.
          1. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458(7239):719-24.
          2. Krontiris TG, Cooper GM. Transforming activity of human tumor DNAs. Proc Natl Acad Sci USA. 1981;78(2):1181-4.
          3. Dias-Santagata D, Akhavanfard S, David SS, Vernovsky K, Kuhlmann G, Boisvert SL, et al. Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine. EMBO Mol Med. 2010;2(5):146-58.
          4. Pao W, Kris MG, Iafrate AJ, Ladanyi M, Jänne PA, Wistuba II, et al. Integration of molecular profiling into the lung cancer clinic. Clin Cancer Res. 2009;15(17):5317-22.
          5. Sequist LV, Heist RS, Shaw AT, Fidias P, Rosovsky R, Temel JS, et al. Implementing multiplexed genotyping of non-smallcell lung cancers into routine clinical practice. Ann Oncol. 2011;22(12):2616-24.
          6. Sun Y, Ren Y, Fang Z, Li C, Fang R, Gao B, et al. Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases. J Clin Oncol. 2010;28(30):4616-20.
          7. Arrieta O, Cardona AF, Federico Bramuglia G, Gallo A, Campos-Parra AD, Serrano S, et al.; CLICaP. Genotyping non-small cell lung cancer (NSCLC) in Latin America. J Thorac Oncol. 2011;6(11):1955-9.
          8. Paik PK, Hasanovic A, Wang L, Rekhtman N, Ladanyi M, Kris MG. Multiplex testing for driver mutations in squamous cell carcinomas of the lung. J Clin Oncol. 2012;30 (suppl; abstr 7505).
          9. Govindan R, Hammerman PS, Hayes DN, Wilkerson MD Baylin S, Meyerson M, on behalf of the Cancer Genome Atlas (TCGA) Group. Comprehensive genomic characterization of squamous cell carcinoma of the lung. J Clin Oncol. 2012;30 (suppl; abstr 7006).
          10. Pérez-Moreno P, Brambilla E, Thomas R, Soria JC. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clin Cancer Res. 2012;18(9):2443-51.
          Sistema OJS 3.4.0.7 - Metabiblioteca |